LGSN
Lengsin
Also known as: GLULD1, LGS, LGSN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TDP6
- Gene
- LGSN
- Ensembl
- ENSG00000146166
- Chromosome
- 6
- Canonical length
- 509 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a protein with similarity to the GS I members of the glutamine synthetase superfamily. The encoded protein is referred to as a pseudo-glutamine synthetase because it has no glutamine synthesis activity and may function as a chaperone protein. This protein is localized to the lens and may be associated with cataract disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
509 residues, UniProt reviewed canonical sequence.
>Q5TDP6|LGSN
1 MNNEEDLLQE DSTRDEGNET EANSMNTLRR TRKKVTKPYV CSTEVGETDM SNSNDCMRDS
61 SQILTPPQLS SRMKHIRQAM AKNRLQFVRF EATDLHGVSR SKTIPAHFFQ EKVSHGVCMP
121 RGYLEVIPNP KDNEMNNIRA TCFNSDIVLM PELSTFRVLP WADRTARVIC DTFTVTGEPL
181 LTSPRYIAKR QLSHLQASGF SLLSAFIYDF CIFGVPEILN SKIISFPALT FLNNHDQPFM
241 QELVDGLYHT GANVESFSSS TRPGQMEISF LPEFGISSAD NAFTLRTGVK EVARKYNYIA
301 SFFIETGFCD SGILSHSLWD VDRKKNMFCS TSGTEQLTIT GKKWLAGLLK HSAALSCLMA
361 PSVSCRKRYS KDRKDLKKSV PTTWGYNDNS CIFNIKCHGE KGTRIENKLG SATANPYLVL
421 AATVAAGLDG LHSSNEVLAG PDESTDFYQV EPSEIPLKLE DALVALEEDQ CLRQALGETF
481 IRYFVAMKKY ELENEEIAAE RNKFLEYFILocalizationUniProt · AlphaFold · HPA
Whether an antibody against LGSN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 3.5 nTPM
Expression across tissuesHPA
Tissue
- liver: 3.5 nTPM
- kidney: 1.8 nTPM
- placenta: 1 nTPM
- spinal cord: 0.4 nTPM
- testis: 0.3 nTPM
- bone marrow: 0.2 nTPM
Single-cell type
- respiratory ciliated cells: 30 nCPM
- proximal tubule cells: 13 nCPM
- parietal cells: 12 nCPM
- late spermatids: 6.2 nCPM
- endometrial ciliated cells: 6 nCPM
- transitional alveolar cells: 5.5 nCPM
Immune cell
- basophil: 0.5 nTPM
- neutrophil: 0.3 nTPM
- plasmacytoid DC: 0.2 nTPM
- memory B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebellum: 1.9 nTPM
- white matter: 1.9 nTPM
- medulla oblongata: 1.7 nTPM
- pons: 1.5 nTPM
- basal ganglia: 1.4 nTPM
- cerebral cortex: 1.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LGSN.
Disease | ImmuneIEDB
Conditions an epitope on LGSN was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.56
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.55
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of LGSN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LGSN as an antibody target. Whether an autoantibody or antibody against LGSN could matter depends on whether native LGSN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LGSN is annotated at the cell surface, where native LGSN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LGSN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...